Guido Bocci, a holder of M.D. and Ph.D. degrees, is an Assistant Professor of pharmacology at the Division of Pharmacology, Department of Internal Medicine, University of Pisa, Italy. His main research activity has been focused on antiangiogenic research, including in vitro and in vivo experimental settings, and clinical pharmacology of chemotherapeutic drugs, including pharmacokinetic and pharmacodynamic studies in cancer patients. Recently, he has been involved in the development of metronomic/antiangiogenic chemotherapy concept in both preclinical and clinical trials, in surrogate markers for antiangiogenic therapies such as monoclonal antibodies and tyrosine kinase inhibitors, and in the pharmacogenetic of drugs used in the treatment of colorectal cancer (including 5-FU and bevacizumab). Among his previous responsibilities, it has been also the interesting experience of direction of the military infirmary at C.I.S.A.M. (S. Piero a Grado) as a Medical Lieutenant of the Italian Army. Bocci was a Residency in Clinical Pharmacology, University of Pisa, Italy, 1995–1999, a Postdoctoral Fellow, Sunnybrook Research Institute, Toronto, ON, Canada, 2000–2003, an Assistant Professor of pharmacology, University of Pisa, Italy, since 2004. Bocci received the Sunnybrook Institute Fellowship Award, University of Toronto, 2002 and the Guido Berlucchi Foundation Prize, awarded to the best young researchers of oncology, 2008.
Biography Updated on 1 December 2011